Companies: 10,795·Total market cap: $144.5T
IMAC Holdings, Inc.

IMAC Holdings, Inc.

BACKOTCHealthcare● Active
$0.04
$-0.00(-4.42%)
Market Cap$155562
P/E Ratio
52W High$0.21
52W Low$0.038
Overview

IMAC Holdings, Inc. (BACK) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

back · pe ratio · data through Dec 31, 2024

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for IMAC Holdings, Inc. (BACK) measures how much investors pay for each dollar of the company's trailing earnings. BACK's current PE ratio of N/A is calculated by dividing its stock price of $0.04 by its TTM earnings per share of -$2.56.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31

Forward P/E
N/A
FY2026 est. EPS $-9.90
Based on 1 analyst
EPS (TTM)
-$2.56
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · IMAC Holdings, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2016 – 2024 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Care Facilities · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
IMAC Holdings, Inc.
IMAC Holdings, Inc.You
BACK
$0MN/A-$2.56
Aclarion, Inc.
Aclarion, Inc.
ACON
$2MN/A-$13.60
BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp.
BCTXW
$0MN/A-$62.95
CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc.
CERO
$0MN/A-$4.71
Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc.
DRMA
$1MN/A-$8.16
NLS Pharmaceutics AG
NLS Pharmaceutics AG
NLSP
$1MN/A-$26.31
Nuwellis, Inc.
Nuwellis, Inc.
NUWE
$0MN/A-$2.54

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 9 of 9 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2024-12-31Latest
FY2024
$-5.76
2023-12-31
FY2023
$-5.82
2022-12-31
FY2022
$-19.43
2021-12-31
FY2021
$-14.02
2020-12-31
FY2020
$-15.11
2019-12-31
FY2019
$-26.90
2018-12-31
FY2018
$-12.65
2017-12-31
FY2017
$-0.38
2016-12-31
FY2016
$-2.56

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for IMAC Holdings, Inc. (BACK) measures how much investors pay for each dollar of the company's trailing earnings. BACK's current PE ratio of N/A is calculated by dividing its stock price of $0.04 by its TTM earnings per share of -$2.56.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.04 ÷ -$2.56 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

BACK pe ratio · 6 questions

BACK's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.04 and TTM EPS of -$2.56. Data sourced from Financial Modeling Prep via BACK's SEC 10-K and 10-Q filings.

BACK PE ratioWhat is BACK PE ratioCurrent PE ratio of BACKBACK PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · IMAC Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09